These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32620082)

  • 1. Vascular function and cardiovascular risk in a HIV infected and HIV free cohort of African ancestry: baseline profile, rationale and methods of the longitudinal EndoAfrica-NWU study.
    Fourie CMT; Botha-Le Roux S; Smith W; Schutte AE; Breet Y; Mels CMC; Gafane-Matemane LF; Lammertyn L; Uys L; Burger A; Joseph JS; Goswami N; De Boever P; Strijdom H
    BMC Infect Dis; 2020 Jul; 20(1):473. PubMed ID: 32620082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk and endothelial function in people living with HIV/AIDS: design of the multi-site, longitudinal EndoAfrica study in the Western Cape Province of South Africa.
    Strijdom H; De Boever P; Walzl G; Essop MF; Nawrot TS; Webster I; Westcott C; Mashele N; Everson F; Malherbe ST; Stanley K; Kessler HH; Stelzl E; Goswami N
    BMC Infect Dis; 2017 Jan; 17(1):41. PubMed ID: 28061822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiometabolic markers to identify cardiovascular disease risk in HIV-infected black South Africans.
    van Rooyen JM; Fourie CM; Steyn HS; Koekemoer G; Huisman HW; Schutte R; Malan L; Glyn M; Smith W; Mels C; Schutte AE
    S Afr Med J; 2014 Mar; 104(3):195-9. PubMed ID: 24897823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial activation and cardiometabolic profiles of treated and never-treated HIV infected Africans.
    Fourie CM; Schutte AE; Smith W; Kruger A; van Rooyen JM
    Atherosclerosis; 2015 May; 240(1):154-60. PubMed ID: 25795556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiometabolic risk in a population of older adults with multiple co-morbidities in rural south africa: the HAALSI (Health and Aging in Africa: longitudinal studies of INDEPTH communities) study.
    Gaziano TA; Abrahams-Gessel S; Gomez-Olive FX; Wade A; Crowther NJ; Alam S; Manne-Goehler J; Kabudula CW; Wagner R; Rohr J; Montana L; Kahn K; Bärnighausen TW; Berkman LF; Tollman S
    BMC Public Health; 2017 Feb; 17(1):206. PubMed ID: 28212629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial structure and function in Africans with HIV for > 5 years: longitudinal relationship with endothelial activation and cardiovascular risk markers.
    Phalane E; Fourie C; Schutte AE; Kruger IM; Mels C
    HIV Med; 2021 Sep; 22(8):650-661. PubMed ID: 33949073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of endothelial function and cardiometabolic profiles of people living with HIV in two South African regions: the EndoAfrica study.
    Swart C; Fourie C; De Boever P; Goswami N; Lammertyn L; Strijdom H; Kamau F; Botha-Le Roux S
    Cardiovasc J Afr; 2022 Jan-Feb 23; 33(1):15-20. PubMed ID: 34378631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between Endothelial Function, Antiretroviral Treatment and Cardiovascular Risk Factors in HIV Patients of African Descent in South Africa: A Cross-Sectional Study.
    Nkeh-Chungag BN; Goswami N; Engwa GA; Sewani-Rusike CR; Mbombela V; Webster I; De Boever P; Kessler HH; Stelzl E; Strijdom H
    J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33498530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease risk in an urban African population: a cross-sectional analysis on the role of HIV and antiretroviral treatment.
    Vos AG; Hoeve K; Barth RE; Peper J; Moorhouse M; Crowther NJ; Venter WDF; Grobbee DE; Bots ML; Klipstein-Grobusch K
    Retrovirology; 2019 Dec; 16(1):37. PubMed ID: 31796103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart Rate Variability, HIV and the Risk of Cardiovascular Diseases in Rural South Africa.
    Godijk NG; Vos AG; Jongen VW; Moraba R; Tempelman H; Grobbee DE; Coutinho RA; Devillé W; Klipstein-Grobusch K
    Glob Heart; 2020 Feb; 15(1):17. PubMed ID: 32489790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Immune Activation in HIV and Non HIV Subjects and Its Relation to Cardiovascular Disease Risk.
    Vos AG; Dodd CN; Delemarre EM; Nierkens S; Serenata C; Grobbee DE; Klipstein-Grobusch K; Venter WDF
    Front Immunol; 2021; 12():647805. PubMed ID: 34290695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of "non-dipping" blood pressure and vascular stiffness in HIV-infected South Africans on antiretrovirals.
    Borkum MS; Heckmann JM; Manning K; Dave JA; Levitt NS; Rayner BL; Wearne N
    PLoS One; 2017; 12(9):e0185003. PubMed ID: 28931072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between antiretroviral therapy and selected cardiovascular disease risk factors in sub-Saharan Africa: A systematic review and meta-analysis.
    Dimala CA; Blencowe H; Choukem SP
    PLoS One; 2018; 13(7):e0201404. PubMed ID: 30059546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease risk and its determinants in people living with HIV across different settings in South Africa.
    Roozen GVT; Vos AG; Tempelman HA; Venter WDF; Grobbee DE; Scheuermaier K; Klipstein-Grobusch K
    HIV Med; 2020 Jul; 21(6):386-396. PubMed ID: 31852030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiometabolic changes in treated versus never treated HIV-infected black South Africans: the PURE study.
    Botha S; Fourie CM; van Rooyen JM; Kruger A; Schutte AE
    Heart Lung Circ; 2014 Feb; 23(2):119-26. PubMed ID: 23978476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of selected non-communicable disease risk factors among HIV patients on anti-retroviral therapy in Bushbuckridge sub-district, Mpumalanga province.
    Mathebula RL; Maimela E; Ntuli NS
    BMC Public Health; 2020 Feb; 20(1):247. PubMed ID: 32070315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study.
    Mehta U; Durrheim DN; Blockman M; Kredo T; Gounden R; Barnes KI
    Br J Clin Pharmacol; 2008 Mar; 65(3):396-406. PubMed ID: 18070223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and risk of cardiovascular disease in sub-Saharan Africa: Rationale and design of the Ndlovu Cohort Study.
    Vos A; Tempelman H; Devillé W; Barth R; Wensing A; Kretzschmar M; Klipstein-Grobusch K; Hoepelman A; Tesselaar K; Aitken S; Madzivhandila M; Uiterwaal C; Venter F; Coutinho R; Grobbee DE
    Eur J Prev Cardiol; 2017 Jul; 24(10):1043-1050. PubMed ID: 28379043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda.
    Buchacz K; Weidle PJ; Moore D; Were W; Mermin J; Downing R; Kigozi A; Borkowf CB; Ndazima V; Brooks JT
    J Acquir Immune Defic Syndr; 2008 Mar; 47(3):304-11. PubMed ID: 18398971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.